[为患有手部和前臂疾病的老年患者提供手术干预麻醉的现代理念]。

Q4 Medicine
K A Eghiazaryan, I G Chulovskaya, A M Shatov, V S Kosmynin, D S Zharov
{"title":"[为患有手部和前臂疾病的老年患者提供手术干预麻醉的现代理念]。","authors":"K A Eghiazaryan, I G Chulovskaya, A M Shatov, V S Kosmynin, D S Zharov","doi":"10.17116/hirurgia202410188","DOIUrl":null,"url":null,"abstract":"<p><p>The article analyzes literature data on the characteristics of local anesthetics used to perform regional anesthesia, and provides a detailed assessment of the drug \"Articaine\". The article presents the results of an open randomized study of the action of the anesthetics \"Articaine-Binergia\" 20 mg/ml and \"Ropivocaine\" used to perform conduction anesthesia in upper limb surgeries. The results of the study demonstrated a high degree of effectiveness of both drugs, but the safety indicators of the drug \"Articaine-Binergia\" 20 mg/ml significantly exceeded those of \"Ropivocaine\". The studies have established that the drug \"Articaine-Binergia\" 20 mg/ml is characterized by a short latent period, which allows for optimization of the operating room. At the same time, the peculiarity of \"Ropivocaine\" was the duration of action, which ensures the possibility of performing long surgical interventions, and maintaining the analgesic effect in the first hours after surgery. The results of the studies allowed us to recommend Articaine-Binergia 20 mg/ml as an effective local analgesic with a high degree of safety for widespread practical use in upper limb surgeries. The use of Ropivacaine for conduction anesthesia should be limited to surgical interventions that last longer than the duration of action of Articaine-Binergia 20 mg/ml, which is 2 hours 20 minutes. In addition, highly traumatic surgical interventions in patients with absolute contraindications to the use of painkillers are a limitation.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 10","pages":"88-96"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The modern concept of anesthesiological provision of surgical interventions in geriatric patients with diseases of the hand and forearm].\",\"authors\":\"K A Eghiazaryan, I G Chulovskaya, A M Shatov, V S Kosmynin, D S Zharov\",\"doi\":\"10.17116/hirurgia202410188\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The article analyzes literature data on the characteristics of local anesthetics used to perform regional anesthesia, and provides a detailed assessment of the drug \\\"Articaine\\\". The article presents the results of an open randomized study of the action of the anesthetics \\\"Articaine-Binergia\\\" 20 mg/ml and \\\"Ropivocaine\\\" used to perform conduction anesthesia in upper limb surgeries. The results of the study demonstrated a high degree of effectiveness of both drugs, but the safety indicators of the drug \\\"Articaine-Binergia\\\" 20 mg/ml significantly exceeded those of \\\"Ropivocaine\\\". The studies have established that the drug \\\"Articaine-Binergia\\\" 20 mg/ml is characterized by a short latent period, which allows for optimization of the operating room. At the same time, the peculiarity of \\\"Ropivocaine\\\" was the duration of action, which ensures the possibility of performing long surgical interventions, and maintaining the analgesic effect in the first hours after surgery. The results of the studies allowed us to recommend Articaine-Binergia 20 mg/ml as an effective local analgesic with a high degree of safety for widespread practical use in upper limb surgeries. The use of Ropivacaine for conduction anesthesia should be limited to surgical interventions that last longer than the duration of action of Articaine-Binergia 20 mg/ml, which is 2 hours 20 minutes. In addition, highly traumatic surgical interventions in patients with absolute contraindications to the use of painkillers are a limitation.</p>\",\"PeriodicalId\":35986,\"journal\":{\"name\":\"Khirurgiya\",\"volume\":\" 10\",\"pages\":\"88-96\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Khirurgiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/hirurgia202410188\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Khirurgiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/hirurgia202410188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

文章分析了用于实施区域麻醉的局麻药特点的文献数据,并对药物 "Articaine "进行了详细评估。文章介绍了对用于上肢手术传导麻醉的麻醉剂 "Articaine-Binergia" 20 mg/ml和 "Ropivocaine "的作用进行公开随机研究的结果。研究结果表明,这两种药物都具有很高的有效性,但 "Articaine-Binergia" 20 毫克/毫升药物的安全指标明显超过 "Ropivocaine"。研究表明,"Articaine-Binergia" 20 毫克/毫升的潜伏期短,可以优化手术室。同时,"罗哌卡因 "的特点是作用持续时间长,这确保了进行长时间外科手术的可能性,并在手术后的最初几个小时内保持镇痛效果。根据研究结果,我们建议将阿替卡因-Binergia 20 毫克/毫升作为一种安全有效的局部镇痛药,在上肢手术中广泛使用。使用罗哌卡因进行传导麻醉应仅限于持续时间超过阿替卡因-宾格亚 20 毫克/毫升作用时间(2 小时 20 分钟)的手术。此外,对使用止痛药有绝对禁忌症的患者进行高创伤性手术干预也是一种限制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[The modern concept of anesthesiological provision of surgical interventions in geriatric patients with diseases of the hand and forearm].

The article analyzes literature data on the characteristics of local anesthetics used to perform regional anesthesia, and provides a detailed assessment of the drug "Articaine". The article presents the results of an open randomized study of the action of the anesthetics "Articaine-Binergia" 20 mg/ml and "Ropivocaine" used to perform conduction anesthesia in upper limb surgeries. The results of the study demonstrated a high degree of effectiveness of both drugs, but the safety indicators of the drug "Articaine-Binergia" 20 mg/ml significantly exceeded those of "Ropivocaine". The studies have established that the drug "Articaine-Binergia" 20 mg/ml is characterized by a short latent period, which allows for optimization of the operating room. At the same time, the peculiarity of "Ropivocaine" was the duration of action, which ensures the possibility of performing long surgical interventions, and maintaining the analgesic effect in the first hours after surgery. The results of the studies allowed us to recommend Articaine-Binergia 20 mg/ml as an effective local analgesic with a high degree of safety for widespread practical use in upper limb surgeries. The use of Ropivacaine for conduction anesthesia should be limited to surgical interventions that last longer than the duration of action of Articaine-Binergia 20 mg/ml, which is 2 hours 20 minutes. In addition, highly traumatic surgical interventions in patients with absolute contraindications to the use of painkillers are a limitation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Khirurgiya
Khirurgiya Medicine-Medicine (all)
CiteScore
0.70
自引率
0.00%
发文量
161
期刊介绍: Хирургия отдельных областей сердце, сосуды легкие пищевод молочная железа желудок и двенадцатиперстная кишка кишечник желчевыводящие пути печень
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信